Vinge advised Fastighets Aktiebolaget Trianon on the deal. Fastighets Aktiebolaget Trianon (publ) completed a directed share issue of SEK 184 million and a tender offer for...
Trianon’s Shares Offering
Active Biotech’s Rights Offering
Vinge advised Active Biotech on the offering. Active Biotech AB (publ) (Nasdaq Stockholm) has carried out a rights issue of approximately SEK 51 million. Active Biotech...
Trianon’s Tender Offering
Vinge advised Fastighets Aktiebolaget Trianon on the deal. Fastighets Aktiebolaget Trianon (publ) completed a partial tender offer for outstanding subordinated perpetual floating rate callable sustainable capital...
Cantargia’s Shares Offering
Vinge advised Cantargia AB on the deal. Cantargia AB (publ) completed a directed share issue of approximately SEK 59 million (approx. $5.4 million) to a number of...
Saga Diagnostics’ Convertible Bonds Offering
Vinge advised SAGA Diagnostics in connection with the transaction. SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue...
Infant Bacterial Therapeutics AB’s Rights Offering
Vinge advised Infant Bacterial Therapeutics AB on the offering. Infant Bacterial Therapeutics AB (publ) completed its rights offering of approximately SEK 100 million. IBT is addressing...
SiB Solutions’ SEK 50 Million Investment Round
Vinge advised SiB Solutions on the deal. SiB Solutions have received a SEK50M investment from Scania Growth Capital II to support their product development and scaling....
BHG Group’s SEK 800 Million Directed Share Issue
Vinge advised BHG Group AB on the deal. BHG Group AB has successfully carried out a directed new issue of 39,024,390 shares, at a subscription price...
Aneo’s Public Offer for Scandinavian Biogas
Vinge advised Aneo on the deal. Cirio advised Scandinavian Biogas. Aneo Renewables Holding AS (“Aneo”) has announced a mandatory cash tender offer for the shares in...
Scandinavian Biogas’ Shares Private Placement
Cirio advised Scandinavian Biogas Fuels International AB on the deal while Vinge advised Aneo. The board of directors of Scandinavian Biogas resolved, subject to subsequent approval...
Active Biotech’s SEK 55 Million Rights Offering
Vinge advised Active Biotech on the deal. Active Biotech AB (publ) (Nasdaq Stockholm) carried out a rights issue of approximately SEK 55 million. Active Biotech is a...
Cantargia’s SEK 250 Million Right Issue
Vinge advised Cantargia AB on the deal. Cantargia AB announced a fully covered new share issue of approximately SEK 250 million with pre-emptive rights for the Company’s...